Citations (242)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Sonia T. Anand, Elizabeth A. Chrischilles, Rebecca J. Baer, Mary E. Charlton, Patrick J. Breheny, William W. Terry, Monica R. McLemore, Deborah A. Karasek, Laura L. Jelliffe-Pawlowski & Kelli K. Ryckman. (2022) The risk of preterm birth among women with a history of leukemia or lymphoma. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 6115-6123.
Read now
Read now
Neha Bansal, Chaitya Joshi, Michael Jacob Adams, Kelley Hutchins, Andrew Ray & Steven E. Lipshultz. (2021) Cardiotoxicity in pediatric lymphoma survivors. Expert Review of Cardiovascular Therapy 19:11, pages 957-974.
Read now
Read now
Changcan Shi, Hongjuan Wu, Ke Xu, Ting Cai, Kunming Qin, Li Wu & Baochang Cai. (2020) Liquiritigenin-Loaded Submicron Emulsion Protects Against Doxorubicin-Induced Cardiotoxicity via Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Activity. International Journal of Nanomedicine 15, pages 1101-1115.
Read now
Read now
Kateryna Petrykey, Gregor U. Andelfinger, Caroline Laverdière, Daniel Sinnett & Maja Krajinovic. (2020) Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer. Expert Opinion on Drug Metabolism & Toxicology 16:10, pages 865-883.
Read now
Read now
Lili Zhang, Kexin Zhu, Hairong Zeng, Jiaxin Zhang, Yiqiong Pu, Zhicheng Wang, Tong Zhang & Bing Wang. (2019) Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. International Journal of Nanomedicine 14, pages 6061-6071.
Read now
Read now
Ying Fang, Hao Wang, Hong-Jing Dou, Xing Fan, Xiao-Chun Fei, Lei Wang, Shu Cheng, Anne Janin, Li Wang & Wei-Li Zhao. (2018) Doxorubicin-loaded dextran-based nano-carriers for highly efficient inhibition of lymphoma cell growth and synchronous reduction of cardiac toxicity. International Journal of Nanomedicine 13, pages 5673-5683.
Read now
Read now
Neha Bansal, Shahnawaz Amdani, Emma R. Lipshultz & Steven E. Lipshultz. (2017) Chemotherapy-induced cardiotoxicity in children. Expert Opinion on Drug Metabolism & Toxicology 13:8, pages 817-832.
Read now
Read now
Jun-Qing Situ, Yi-Qing Ye, Xiu-Liang Zhu, Ri-Sheng Yu, Jian You, Hong Yuan, Fu-Qiang Hu & Yong-Zhong Du. (2015) Specific targeting of A54 homing peptide-functionalized dextran-g-poly(lactic-co-glycolic acid) micelles to tumor cells. International Journal of Nanomedicine 10, pages 665-675.
Read now
Read now
Ruth Pettengell & Jasvinder Kaur. (2015) Pixantrone dimaleate for treating non-Hodgkin’s lymphoma. Expert Opinion on Orphan Drugs 3:6, pages 747-757.
Read now
Read now
Pier Luigi Zinzani, Massimo Federico, Stefano Oliva, Antonello Pinto, Luigi Rigacci, Giorgina Specchia, Alessandra Tucci & Umberto Vitolo. (2015) The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma. Leukemia & Lymphoma 56:1, pages 12-25.
Read now
Read now
Samit Patel, Michaela Liedtke, Dat Ngo & Bruno C. Medeiros. (2013) A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia. Leukemia & Lymphoma 54:10, pages 2231-2235.
Read now
Read now
Patricia Zerra, Thomas R Cochran, Vivian I Franco & Steven E Lipshultz. (2013) An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies. Expert Opinion on Pharmacotherapy 14:11, pages 1497-1513.
Read now
Read now
Pierantonio Menna, Odalys Gonzalez Paz, Massimo Chello, Elvio Covino, Emanuela Salvatorelli & Giorgio Minotti. (2012) Anthracycline cardiotoxicity. Expert Opinion on Drug Safety 11:sup1, pages S21-S36.
Read now
Read now
Smita Bhatia. (2011) Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up. Expert Review of Hematology 4:4, pages 437-454.
Read now
Read now
Articles from other publishers (228)
Theodorus W. Kouwenberg, Elvira C. van Dalen, Elizabeth A. M. Feijen, Stejara A. Netea, Melissa Bolier, Martijn G. Slieker, Firdaus A. A. Mohamed Hoesein, Leontien C. M. Kremer, Heynric B. Grotenhuis & Annelies M. C. Mavinkurve-Groothuis. (2023) Acute and early-onset cardiotoxicity in children and adolescents with cancer: a systematic review. BMC Cancer 23:1.
Crossref
Crossref
Nicoletta Bertorello, Roberto Luksch, Gianni Bisogno, Riccardo Haupt, Paolo Spallarossa, Rosita Cenna & Franca Fagioli. (2023) Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane. Pediatric Blood & Cancer 70:9.
Crossref
Crossref
Drishti Tolani, Julia Wilcox, Sharvari Shyam & Neha Bansal. (2023) Cardio-oncology for Pediatric and Adolescent/Young Adult Patients. Current Treatment Options in Oncology 24:8, pages 1052-1070.
Crossref
Crossref
Hoda E. Mohamed, Mervat E. Askar, Mohamed A. Shaheen, Alaa E. Salama, Reham A. Idris & Nahla N. Younis. (2023) Infliximab substantially re‐silenced Wnt/β‐catenin signaling and ameliorated doxorubicin‐induced cardiomyopathy in rats. Journal of Biochemical and Molecular Toxicology 37:5.
Crossref
Crossref
Wafaa S. El-Sherbeny, Nesreen M. Sabry, Shaimaa B. El-Saied & Basma Elnagar. (2023) Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy. Cardio-Oncology 9:1.
Crossref
Crossref
Varsha G. Desai, Ana Azevedo‐Pouly, Vikrant Vijay, Bounleut Phanavanh, Carrie L. Moland, Tao Han, Javier Revollo, Baikuntha Aryal, V. Ashutosh Rao & James C. Fuscoe. (2022) Potential role of the apelin‐APJ pathway in sex‐related differential cardiotoxicity induced by doxorubicin in mice. Journal of Applied Toxicology 43:4, pages 557-576.
Crossref
Crossref
Narmin Hamaamin Hussen, Aso Hameed Hasan, Gashbeen Osman Muhammed, Akar Yousif Yassin, Roza Rafiq Salih, Parwa Ahmed Esmail, Mohammed M. Alanazi & Joazaizulfazli Jamalis. (2023) Anthracycline in Medicinal Chemistry: Mechanism of Cardiotoxicity, Preventive and
Treatment Strategies. Current Organic Chemistry 27:4, pages 363-377.
Crossref
Crossref
Muhammad Saghir Khan, Luca Szalontay & Aziza T. Shad. 2022. Pediatric Surgical Oncology. Pediatric Surgical Oncology
1
24
.
Milena dos Santos Barros Campos, Roberta Helena Fernandes Feitosa, Carolina Christianini Mizzaci, Maria do Rosário Toscano von Flach, Betty Janny Maia Siqueira & Luiz EduardoMastrocola. (2022) Os Benefícios dos Exercícios Físicos no Câncer de Mama. Arquivos Brasileiros de Cardiologia 119:6, pages 981-990.
Crossref
Crossref
Neha Bansal, Carol Fernandez Hazim, Sergio Badillo, Sharvari Shyam, Diana Wolfe, Anna E. Bortnick, Mario J. Garcia, Carols J. Rodriguez & Lili Zhang. (2022) Maternal Cardiovascular Outcomes of Pregnancy in Childhood, Adolescent, and Young Adult Cancer Survivors. Journal of Cardiovascular Development and Disease 9:11, pages 373.
Crossref
Crossref
E. A. Kuzheleva, A. A. Garganeeva, O. V. Tukish, M. Y. Kondratiev, K. N. Vitt & V. I. Chernov. (2022) Review of potential predictors of anthracycline-induced cardiotoxicity from the position of disease pathogenesis. The Siberian Journal of Clinical and Experimental Medicine 37:3, pages 19-28.
Crossref
Crossref
Jiabao Zhu, Shuhui Xie, Hanzhen Ji, Xingxing Gu & Jing Wu. (2022) Evaluation of anthracycline-induced subclinical LV dysfunction by using myocardial composite index and two-dimension speckle tracking echocardiography technique. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Sonia T. Anand, Kelli K. Ryckman, Rebecca J. Baer, Mary E. Charlton, Patrick J. Breheny, William W. Terry, Monica R. McLemore, Deborah A. Karasek, Laura L. Jelliffe-Pawlowski & Elizabeth A. Chrischilles. (2022) Hypertensive disorders of pregnancy among women with a history of leukemia or lymphoma. Pregnancy Hypertension 29, pages 101-107.
Crossref
Crossref
P. Gibelin. (2022) Cardiomyopathies aux anthracyclines : détection des patients à risque (résultats de l’observatoire national OFECPACA). Bulletin de l'Académie Nationale de Médecine 206:5, pages 676-683.
Crossref
Crossref
Oytun Erbaş, İlknur Altuntaş, Özge Çağlar, Elif Özyilmaz, Ece Sari, İlayda Üzümcü & Kaan Erbakan. 2022. Risk Factors for Cardiovascular Disease. Risk Factors for Cardiovascular Disease.
Jessica L Vargas-Neri, Bruce Carleton, Colin J Ross, Mara Medeiros, Gilberto Castañeda-Hernández & Patricia Clark. (2022) Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients. Pharmacogenomics 23:5, pages 291-301.
Crossref
Crossref
Dipika Menon, Gilda Kadiu, Yamuna Sanil & Sanjeev Aggarwal. (2021) Anthracycline Treatment and Left Atrial Function in Children: A Real-Time 3-Dimensional Echocardiographic Study. Pediatric Cardiology 43:3, pages 645-654.
Crossref
Crossref
Lingling Huang, Jianmiao Yang, Tiantian Wang, Jianqing Gao & Donghang Xu. (2022) Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Li Wu, Yan Shi, Zihui Ni, Tao Yu & Zhipeng Chen. (2021) Preparation of a Self-Assembled Rhein–Doxorubicin Nanogel Targeting Mitochondria and Investigation on Its Antihepatoma Activity. Molecular Pharmaceutics 19:1, pages 35-50.
Crossref
Crossref
Alejandro Velasco-Ruiz, Rocio Nuñez-Torres, Guillermo Pita, Hans Wildiers, Diether Lambrechts, Sigrid Hatse, Danielle Delombaerde, Thomas Van Brussel, M. Rosario Alonso, Nuria Alvarez, Belen Herraez, Christof Vulsteke, Pilar Zamora, Teresa Lopez-Fernandez & Anna Gonzalez-Neira. (2021) POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients. Pharmaceutics 13:11, pages 1942.
Crossref
Crossref
Kateryna Petrykey, Aziz M Rezgui, Mathilde Le Guern, Patrick Beaulieu, Pascal St-Onge, Simon Drouin, Laurence Bertout, Fan Wang, Jessica L Baedke, Yutaka Yasui, Melissa M Hudson, Marie-Josée Raboisson, Caroline Laverdière, Daniel Sinnett, Gregor U Andelfinger & Maja Krajinovic. (2021) Genetic factors in treatment-related cardiovascular complications in survivors of childhood acute lymphoblastic leukemia. Pharmacogenomics 22:14, pages 885-901.
Crossref
Crossref
Agata Bikiewicz, Maciej Banach, Stephan von Haehling, Marek Maciejewski & Agata Bielecka‐Dabrowa. (2021) Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications. ESC Heart Failure 8:4, pages 2397-2418.
Crossref
Crossref
Atsushi Makimoto, Jun Fang & Hiroshi Maeda. (2021) Development of a Selective Tumor-Targeted Drug Delivery System: Hydroxypropyl-Acrylamide Polymer-Conjugated Pirarubicin (P-THP) for Pediatric Solid Tumors. Cancers 13:15, pages 3698.
Crossref
Crossref
Smita Bhatia. 2021. Blood and Marrow Transplantation Long Term Management. Blood and Marrow Transplantation Long Term Management
92
100
.
Chia-Ying Lien, Chen-Wen Lu, Yi-Hsuan Lin, Wan-Jhen Wu, Chih-Hsiang Hsu, Tai-Yuan Chuang, Kuei-Fu Lin, Wu-Chang Chuang, Ming-Chung Lee & Chung-Hsin Wu. (2021) Chinese Herbal Medicine, Guilu Erxian Glue, as Alternative Medicine for Adverse Side Effects of Chemotherapy in Doxorubicin-Treated Cell and Mouse Models. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-11.
Crossref
Crossref
Fangying Yan, Rongchen Liu, Xinyu Zhuang, Ruoshui Li, Haiming Shi & Xiufang Gao. (2020) Salidroside Attenuates Doxorubicin-Induced Cardiac Dysfunction Partially Through Activation of QKI/FoxO1 Pathway. Journal of Cardiovascular Translational Research 14:2, pages 355-364.
Crossref
Crossref
Kadry M. Sadek, Sahar F. E. Mahmoud, Mohamed F. Zeweil & Tarek K. Abouzed. (2021)
Proanthocyanidin alleviates doxorubicin‐induced cardiac injury by inhibiting NF‐
k
B pathway and modulating oxidative stress, cell cycle, and fibrogenesis
. Journal of Biochemical and Molecular Toxicology 35:4.
Crossref
Crossref
Silvia Fernández-Francos, Noemi Eiro, Luis A. Costa, Sara Escudero-Cernuda, María Luisa Fernández-Sánchez & Francisco J. Vizoso. (2021) Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine. International Journal of Molecular Sciences 22:7, pages 3576.
Crossref
Crossref
Timothy N. McOwan, Lauren A. Craig, Anne Tripdayonis, Kathy Karavendzas, Michael M. Cheung, Enzo R. Porrello, Rachel Conyers & David A. Elliott. (2020) Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy. Cardio-Oncology 6:1.
Crossref
Crossref
Wang Yadi, Chen Shurui, Zhang Tong, Chen Suxian, Tong Qing & He Dongning. (2020) Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity. BMC Cardiovascular Disorders 20:1.
Crossref
Crossref
Mohamed Nagy, Mohamed Attya & George P Patrinos. (2020) Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies. Pharmacogenomics 21:17, pages 1247-1264.
Crossref
Crossref
Nadia Fattahi, Mohammad-Ali Shahbazi, Aziz Maleki, Mehrdad Hamidi, Ali Ramazani & Hélder A. Santos. (2020) Emerging insights on drug delivery by fatty acid mediated synthesis of lipophilic prodrugs as novel nanomedicines. Journal of Controlled Release 326, pages 556-598.
Crossref
Crossref
Wendy J Bottinor, Jonathan H Soslow, Justin Godown, Marcus F Stoddard, Evan C Osmundson, Carrie G Lenneman, Debra L Friedman & Scott C Borinstein. (2020) Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imaging. American Heart Journal 226, pages 127-139.
Crossref
Crossref
Kelly D. Getz, Lillian Sung, Todd A. Alonzo, Kasey J. Leger, Robert B. Gerbing, Jessica A. Pollard, Todd Cooper, E. Anders Kolb, Alan S. Gamis, Bonnie Ky & Richard Aplenc. (2020) Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children’s Oncology Group. Journal of Clinical Oncology 38:21, pages 2398-2406.
Crossref
Crossref
Katayoon Hafezi, Ali Asghar Hemmati, Hassan Abbaszadeh, Armita Valizadeh & Manoochehr Makvandi. (2020)
Anticancer activity and molecular mechanisms of α‐conidendrin, a polyphenolic compound present in
Taxus yunnanensis
, on human breast cancer cell lines
. Phytotherapy Research 34:6, pages 1397-1408.
Crossref
Crossref
Carmine RoccaTeresa PasquaMaria Carmela CerraTommaso Angelone. (2020) Cardiac Damage in Anthracyclines Therapy: Focus on Oxidative Stress and Inflammation. Antioxidants & Redox Signaling 32:15, pages 1081-1097.
Crossref
Crossref
Patrick Tran & Prithwish Banerjee. (2020) Iatrogenic Decompensated Heart Failure. Current Heart Failure Reports 17:2, pages 21-27.
Crossref
Crossref
Yanzhe Qin & Xinwen Peng. (2020) Synthesis of Biocompatible Cholesteryl–Carboxymethyl Xylan Micelles for Tumor-Targeting Intracellular DOX Delivery. ACS Biomaterials Science & Engineering 6:3, pages 1582-1589.
Crossref
Crossref
Neha Bansal, Javier G. Blanco, Umesh C. Sharma, Saraswati Pokharel, Shannon Shisler & Steven E. Lipshultz. (2020) Cardiovascular diseases in survivors of childhood cancer. Cancer and Metastasis Reviews 39:1, pages 55-68.
Crossref
Crossref
Lanchun Liu, Chao Liu, Lian Duan, Jing Bai, Qiyuan Mao & Wang Jie. (2020) Shengmai injection combined with conventional therapy in treating Adriamycin-related cardiotoxicity. Medicine 99:45, pages e23084.
Crossref
Crossref
Cai Xinyong, Zeng Zhiyi, Hong Lang, Yan Peng, Wu Xiaocheng, Zhang Ping & Shao Liang. (2020) The role of toll-like receptors in myocardial toxicity induced by doxorubicin. Immunology Letters 217, pages 56-64.
Crossref
Crossref
Kleopatra Eleftheriou, Archontia Kaminari, Katerina N. Panagiotaki, Zili Sideratou, Michael Zachariadis, Jane Anastassopoulou & Dimitris Tsiourvas. (2020) A combination drug delivery system employing thermosensitive liposomes for enhanced cell penetration and improved in vitro efficacy. International Journal of Pharmaceutics 574, pages 118912.
Crossref
Crossref
Berthe M. P. Aleman & David J. Cutter. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma
465
483
.
Jock Chichaco Kuruc, Armando A. Durant-Archibold, Jorge Motta, K. S. Rao, Barry Trachtenberg, Carlos Ramos, Hongyu Wang, David Gorenstein, Fredrik Vannberg & King Jordan. (2019) Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report. BMC Cardiovascular Disorders 19:1.
Crossref
Crossref
Yang Song, Yuan Zhang, Wei-Peng Zhang, Bao-Zhen Zhang, Ke-Fei Wang & Xue-Song Feng. (2019) Interaction Effects between Doxorubicin and Hernandezine on the Pharmacokinetics by Liquid Chromatography Coupled with Mass Spectrometry. Molecules 24:19, pages 3622.
Crossref
Crossref
Abdelrahman Ibrahim Abushouk, Amr Muhammad Abdo Salem, Anas Saad, Ahmed M. Afifi, Abdelrahman Yousry Afify, Hesham Afify, Hazem S.E. Salem, Esraa Ghanem & Mohamed M. Abdel-Daim. (2019) Mesenchymal Stem Cell Therapy for Doxorubicin-Induced Cardiomyopathy: Potential Mechanisms, Governing Factors, and Implications of the Heart Stem Cell Debate. Frontiers in Pharmacology 10.
Crossref
Crossref
Yutong Wang, Li Bao, Bin Chu, Shan Gao, Minqiu Lu, Lei Shi, Lina Fu, Lijuan Fang & Qiuqing Xiang. (2019) Progressive Elevation of NT-ProBNP During Chemotherapy Is Related to Asymptomatic Cardiovascular Events in Patients With Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 19:3, pages 167-176.e1.
Crossref
Crossref
Qiming Chen & Liming Zhao. 2019. Oligosaccharides of Chitin and Chitosan. Oligosaccharides of Chitin and Chitosan
275
288
.
A. MASOPUSTOVÁ, P. JEHLIČKA, M. HUML, T. VOTAVA, L. TREFIL, M. KRESLOVÁ & J. SÝKORA. (2018) Plethysmographic and Biochemical Markers in the Diagnosis of Endothelial Dysfunction in Pediatric Acute Lymphoblastic Leukemia Survivors – New Applications. Physiological Research, pages 903-909.
Crossref
Crossref
Xiantao Qin, Fangyuan Chang, Zhenfeng Wang & Wenying Jiang. (2018) Correlation of circulating pro-angiogenic miRNAs with cardiotoxicity induced by epirubicin/cyclophosphamide followed by docetaxel in patients with breast cancer. Cancer Biomarkers 23:4, pages 473-484.
Crossref
Crossref
Samira R Mansour, Heba N Gad EL-Hak & Abdelraouf A Moustafa. (2018) Influence of injection mode and antioxidant dietary on the toxicity of Doxorubicin as a chemotherapy drug. Gastroenterology & Hepatology: Open Access 9:6.
Crossref
Crossref
Ricardo Simões, Luciana Maria Silva, André Luiz Valle Mussi Cruz, Vanessa Gomes Fraga, Adriano de Paula Sabino & Karina Braga Gomes. (2018) Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review. Biomedicine & Pharmacotherapy 107, pages 989-996.
Crossref
Crossref
Jay Voit, Anjan Tibrewala & Nausheen Akhter. (2018) Heart of the matter: reverse takotsubo syndrome in an anthracycline-exposed oncology patient. BMJ Case Reports, pages bcr-2018-226378.
Crossref
Crossref
Priya Weerasinghe, Sarathi Hallock, Robert Brown & L. Maximilian Buja. 2018. Apoptosis and Beyond. Apoptosis and Beyond
567
582
.
Neha Bansal, Mariana Gerschenson, Tracie L. Miller, Stephen E. Sallan, Jason Czachor, Hiedy Razoky, Ashley Hill, Miriam Mestre & Steven E. Lipshultz. 2018. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants
529
546
.
Francois Dionne, Folefac Aminkeng, Amit P. Bhavsar, Gabriella Groeneweg, Anne Smith, Henk Visscher, Shahrad Rod Rassekh, Colin Ross & Bruce Carleton. (2018) An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines. Pediatric Blood & Cancer 65:3, pages e26887.
Crossref
Crossref
Jianjian Shi, Michelle Surma & Lei Wei. (2018) Disruption of ROCK1 gene restores autophagic flux and mitigates doxorubicin-induced cardiotoxicity. Oncotarget 9:16, pages 12995-13008.
Crossref
Crossref
Emily Tonorezos, Shrujal S. Baxi, Victoria Blinder, Darren R. Feldman, Danielle Novetsky Friedman, Matthew Matasar, Talya Salz, Armin Shahrokni & Kevin C. Oeffinger. 2018. The American Cancer Society's Principles of Oncology. The American Cancer Society's Principles of Oncology
419
436
.
Lina Liang, Jun Fu & Liyan Qiu. (2018) Design of pH-Sensitive Nanovesicles via Cholesterol Analogue Incorporation for Improving in Vivo Delivery of Chemotherapeutics. ACS Applied Materials & Interfaces 10:6, pages 5213-5226.
Crossref
Crossref
Robert W. Loar, Cory V. Noel, Hari Tunuguntla, John L. Colquitt & Ricardo H. Pignatelli. (2018) State of the art review: Chemotherapy-induced cardiotoxicity in children. Congenital Heart Disease 13:1, pages 5-15.
Crossref
Crossref
Donato Cappetta, Francesca Rossi, Elena Piegari, Federico Quaini, Liberato Berrino, Konrad Urbanek & Antonella De Angelis. (2018) Doxorubicin targets multiple players: A new view of an old problem. Pharmacological Research 127, pages 4-14.
Crossref
Crossref
Neha Bansal, Jyothsna Akam-Venkata, Vivian I. Franco & Steven E. Lipshultz. 2018. Heart Failure in the Child and Young Adult. Heart Failure in the Child and Young Adult
425
443
.
T.R. Cochran, V.I. Franco, R. Scully & S.E. Lipshultz. 2018. Comprehensive Toxicology. Comprehensive Toxicology
432
446
.
Sara Ruiz-Pinto, Guillermo Pita, Miguel Martín, Teresa Alonso-Gordoa, Daniel R. Barnes, María R. Alonso, Belén Herraez, Purificación García-Miguel, Javier Alonso, Antonio Pérez-Martínez, Antonio J. Cartón, Federico Gutiérrez-Larraya, José A. García-Sáenz, Javier Benítez, Douglas. F. Easton, Ana Patiño-García & Anna González-Neira. (2017) Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients. Breast Cancer Research and Treatment 167:1, pages 249-256.
Crossref
Crossref
Asmaa F. Khafaga & Yasser S. El-Sayed. (2017) All-trans-retinoic acid ameliorates doxorubicin-induced cardiotoxicity: in vivo potential involvement of oxidative stress, inflammation, and apoptosis via caspase-3 and p53 down-expression. Naunyn-Schmiedeberg's Archives of Pharmacology 391:1, pages 59-70.
Crossref
Crossref
Rohit Moudgil & Edward T. H. Yeh. 2018. Cancer and Cardiovascular Disease. Cancer and Cardiovascular Disease
55
69
.
Adriana D. Oprea, Raymond R. Russell, Kerry S. Russell & Maysa Abu-Khalaf. (2017) Chemotherapy Agents With Known Cardiovascular Side Effects and Their Anesthetic Implications. Journal of Cardiothoracic and Vascular Anesthesia 31:6, pages 2206-2226.
Crossref
Crossref
Chang Lu, Yue Zhao, Wei-Qi Jia, Hui Zhang, Huan Qi, Wen-Sheng Xiang, Ji-Dong Wang & Xiang-Jing Wang. (2017) A new anthracycline-type metabolite from Streptomyces sp. NEAU-L3. The Journal of Antibiotics 70:10, pages 1026-1028.
Crossref
Crossref
Jun Huang, Zi-Ning Yan, Yi-Fei Rui, Dan Shen, Li Fan & Dong-Liang Chen. (2017) Longitudinal rotation: a new way to detect the cardiotoxicity of anthracycline-based chemotherapy in breast cancer patients. Oncotarget 8:41, pages 70072-70083.
Crossref
Crossref
Fan Xu, Xiao Li, Lanfang Liu, Xu Xiao, Li Zhang, Shenglin Zhang, Pingping Lin, Xiaojie Wang, Yongwei Wang & Qingshan Li. (2017) Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression. Experimental and Therapeutic Medicine 14:3, pages 2216-2220.
Crossref
Crossref
Joydeep Ghosh & Jyoti Bajpai. (2017) Chemotherapy for osteosarcoma: Adverse effects and remedial measures. Pediatric Hematology Oncology Journal 2:2, pages 41-47.
Crossref
Crossref
Sebastian Weis, Ignacio Rubio, Kristin Ludwig, Cynthia Weigel & Elisa Jentho. (2017) Hormesis and Defense of Infectious Disease. International Journal of Molecular Sciences 18:6, pages 1273.
Crossref
Crossref
Abdelrahman Ibrahim Abushouk, Ammar Ismail, Amr Muhammad Abdo Salem, Ahmed M. Afifi & Mohamed M. Abdel-Daim. (2017) Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomedicine & Pharmacotherapy 90, pages 935-946.
Crossref
Crossref
Ying Pang, Chunzhang Yang, Jan Schovanek, Herui Wang, Petra Bullova, Veronika Caisova, Garima Gupta, Katherine I. Wolf, Gregg L. Semenza, Zhengping Zhuang & Karel Pacak. (2017) Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway. Oncotarget 8:14, pages 22313-22324.
Crossref
Crossref
Kirsten Rose-Felker, William L. Border, Borah J. Hong & Eric J. Chow. (2017) Cardio-oncology Related to Heart Failure. Heart Failure Clinics 13:2, pages 311-325.
Crossref
Crossref
Kelley K. Hutchins, Hani Siddeek, Vivian I. Franco & Steven E. Lipshultz. (2017) Prevention of cardiotoxicity among survivors of childhood cancer. British Journal of Clinical Pharmacology 83:3, pages 455-465.
Crossref
Crossref
Swantje Völler, Georg Hempel, Gudrun Würthwein, Alan V. Boddy, Miriam Krischke, Nicolas André, Maurizio D’Incalci, Gianni Bisogno & Joachim Boos. (2016) Towards a Model-Based Dose Recommendation for Doxorubicin in Children. Clinical Pharmacokinetics 56:3, pages 215-223.
Crossref
Crossref
Pierantonio Menna & Emanuela Salvatorelli. (2017) Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview. Chemotherapy 62:3, pages 159-168.
Crossref
Crossref
Steven Zgleszewski, Salvatore R. Goodwin, Kevin J. Sullivan, Franklyn P. Cladis & Peter J. Davis. 2017. Smith's Anesthesia for Infants and Children. Smith's Anesthesia for Infants and Children
1169
1177.e1
.
S.E. Lipshultz, N. Patel, V.I. Franco & S. Fisher. 2017. Cardio-Oncology. Cardio-Oncology
173
186
.
G. Biasillo, C.M. Cipolla & D. Cardinale. 2017. Cardio-Oncology. Cardio-Oncology
107
122
.
Luca Szalontay & Aziza Shad. 2017. Sarcoma. Sarcoma
383
411
.
Francesca Cairello, Sara Pessano, Vera Morsellino, Riccardo Haupt & Maria Derchi. 2017. Manual of Cardio-oncology. Manual of Cardio-oncology
215
242
.
A. Potier, S. Ederhy, Y. Ancedy, M. Chauvet, A. Etienney, L. Soulat-Dufour, S. Adavane-Scheublé, F. Boccara & A. Cohen. (2016) Insuffisance cardiaque et chimiothérapie. Archives des Maladies du Coeur et des Vaisseaux - Pratique 2016:253, pages 3-8.
Crossref
Crossref
Shimaa M. ElshazlyAmr A.A. MahmoudWaleed Barakat. (2016) Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats. Canadian Journal of Physiology and Pharmacology 94:11, pages 1170-1177.
Crossref
Crossref
Folefac Aminkeng, Colin J. D. Ross, Shahrad R. Rassekh, Soomi Hwang, Michael J. Rieder, Amit P. Bhavsar, Anne Smith, Shubhayan Sanatani, Karen A. Gelmon, Daniel Bernstein, Michael R. Hayden, Ursula Amstutz & Bruce C. Carleton. (2016) Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity. British Journal of Clinical Pharmacology 82:3, pages 683-695.
Crossref
Crossref
Liisa S. Järvelä, Markku Saraste, Harri Niinikoski, Jarna C. Hannukainen, Olli J. Heinonen, Päivi M. Lähteenmäki, Mikko Arola & Jukka Kemppainen. (2016) Home-Based Exercise Training Improves Left Ventricle Diastolic Function in Survivors of Childhood ALL: A Tissue Doppler and Velocity Vector Imaging Study. Pediatric Blood & Cancer 63:9, pages 1629-1635.
Crossref
Crossref
Robert L. PageIIII, Cindy L. O’Bryant, Davy Cheng, Tristan J. Dow, Bonnie Ky, C. Michael Stein, Anne P. Spencer, Robin J. Trupp & JoAnn Lindenfeld. (2016) Drugs That May Cause or Exacerbate Heart Failure. Circulation 134:6.
Crossref
Crossref
Maria-Claudia Campagna. (2016) Chemotherapy Complications. Hospital Medicine Clinics 5:3, pages 400-412.
Crossref
Crossref
Agathe Potier, Stéphane Ederhy, Yann Ancedy, Arnaud Etienney, Laurie Soulat-Dufour, Marion Chauvet, Antoine Hollebecque, Saroumadi Adavane-Scheuble, Franck Boccara, Jean-Charles Soria & Ariel Cohen. (2016) Stratégie de dépistage précoce de la toxicité cardiaque secondaire aux anthracyclines et thérapies moléculaires ciblées. Bulletin du Cancer 103:7-8, pages 667-673.
Crossref
Crossref
Jyothsna Akam-Venkata, Vivian I. Franco & Steven E. Lipshultz. (2016) Late Cardiotoxicity: Issues for Childhood Cancer Survivors. Current Treatment Options in Cardiovascular Medicine 18:7.
Crossref
Crossref
Carrie C. Hoefer, Rachael Hageman Blair & Javier G. Blanco. (2016) Development of a CART Model to Predict the Synthesis of Cardiotoxic Daunorubicinol in Heart Tissue Samples From Donors With and Without Down Syndrome. Journal of Pharmaceutical Sciences 105:6, pages 2005-2008.
Crossref
Crossref
Jing Shi, Ye Guo, Leilei Cheng, Feiyan Song & Xianhong Shu. (2016) Early change in left atrial function in patients treated with anthracyclines assessed by real-time three-dimensional echocardiography. Scientific Reports 6:1.
Crossref
Crossref
Pier P. Bassareo, Ines Monte, Claudia Romano, Martino Deidda, Alessandra Piras, Lucia Cugusi, Carmela Coppola, Francesca Galletta & Giuseppe Mercuro. (2016) Cardiotoxicity from anthracycline and cardioprotection in paediatric cancer patients. Journal of Cardiovascular Medicine 17, pages e55-e63.
Crossref
Crossref
J. Gallay-Lepoutre, M.C. Bélanger & M.E. Nadeau.. (2016) Prospective evaluation of Doppler echocardiography, tissue Doppler imaging and biomarkers measurement for the detection of doxorubicin-induced cardiotoxicity in dogs: A pilot study. Research in Veterinary Science 105, pages 153-159.
Crossref
Crossref
Steven E. Lipshultz, Lynn M. Anderson, Tracie L. Miller, Mariana Gerschenson, Kristen E. Stevenson, Donna S. Neuberg, Vivian I. Franco, Daniel E. LiButti, Lewis B. Silverman, Lynda M. Vrooman & Stephen E. Sallan. (2016) Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors. Cancer 122:6, pages 946-953.
Crossref
Crossref
Jan Hintzpeter, Jan Moritz Seliger, Jakub Hofman, Hans-Joerg Martin, Vladimir Wsol & Edmund Maser. (2016) Inhibition of human anthracycline reductases by emodin — A possible remedy for anthracycline resistance. Toxicology and Applied Pharmacology 293, pages 21-29.
Crossref
Crossref
Joel Morganroth, Kristen K. Flaharty, Simona Parisi & Cecilia Moresino. (2015) Effect of single doses of IV palonosetron, up to 2.25 mg, on the QTc interval duration: a double-blind, randomized, parallel group study in healthy volunteers. Supportive Care in Cancer 24:2, pages 621-627.
Crossref
Crossref
MI-HUA LIU, XIAO-LONG LIN, CONG YUAN, JUN HE, TIAN-PING TAN, SHAO-JIAN WU, SHAN YU, LI CHEN, JUN LIU, WEI TIAN, YU-DAN CHEN, HONG-YUN FU, JIAN LI & YUAN ZHANG. (2016) Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells. Molecular Medicine Reports 13:1, pages 367-372.
Crossref
Crossref
Robin K. Kuriakose, Rakesh C. Kukreja & Lei Xi. (2016) Potential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer Drugs. Oxidative Medicine and Cellular Longevity 2016, pages 1-9.
Crossref
Crossref
Shahnawaz M. Amdani, Neha Bansal, Vivian I. Franco, Michael Jacob Adams & Steven E. Lipshultz. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology
397
431
.
Rohit Moudgil & Edward T.H. Yeh. 2016. Clinical Cardio-Oncology. Clinical Cardio-Oncology
133
161
.
Gina Biasillo & Daniela Cardinale. 2016. Current Approach to Heart Failure. Current Approach to Heart Failure
511
533
.
Guanlian Hu, Huiqing Zhang, Li Zhang, Shaobo Ruan, Qin He & Huile Gao. (2015) Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment. International Journal of Pharmaceutics 496:2, pages 1057-1068.
Crossref
Crossref
Joy Marie Fulbright, Daniela E. Egas-Bejar, Winston W. Huh & Joya Chandra. (2015) Analysis of redox and apoptotic effects of anthracyclines to delineate a cardioprotective strategy. Cancer Chemotherapy and Pharmacology 76:6, pages 1297-1307.
Crossref
Crossref
Ronald M. WittelesXavier Bosch. (2015) Myocardial Protection During Cardiotoxic Chemotherapy. Circulation 132:19, pages 1835-1845.
Crossref
Crossref
Emanuel F. Petricoin, Mark M. Ross, Weidong Zhou, Davide Tamburro, Alessandra Luchini, Lance A. Liotta, Eugene H. Herman, Rebecca E. Scully, Tracie L. Miller, Vivian I. Franco, Stephen E. Sallan & Steven E. Lipshultz. (2015) Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification. Progress in Pediatric Cardiology 39:2, pages 85-91.
Crossref
Crossref
Swantje Völler, Joachim Boos, Miriam Krischke, Gudrun Würthwein, Nina E. Kontny, Alan V. Boddy & Georg Hempel. (2015) Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer. Clinical Pharmacokinetics 54:11, pages 1139-1149.
Crossref
Crossref
Folefac Aminkeng, Amit P Bhavsar, Henk Visscher, Shahrad R Rassekh, Yuling Li, Jong W Lee, Liam R Brunham, Huib N Caron, Elvira C van Dalen, Leontien C Kremer, Helena J van der Pal, Ursula Amstutz, Michael J Rieder, Daniel Bernstein, Bruce C Carleton, Michael R Hayden, Colin J D Ross, Michael R Hayden, Bruce C Carleton, Colin J D Ross, Stuart MacLeod, Anne Smith, Claudette Hildebrand, Reza Ghannadan, Shahrad R Rassekh, Henk Visscher, Folefac Aminkeng, Fudan Miao, Michelle Higginson, Nasim Massah, Adrienne Borrie, Ursula Amstutz, Shevaun Hughes, Kaitlyn Shaw, Satvir Dhoot, Amit P Bhavsar, Yuling Li, Jong W Lee, Kaarina Kowalec, Jessica Stortz, Tessa Bendyshe-Walton, Duncan Waltrip, Rachel Bader, Cheri Nijssen-Jordan, David Johnson, Linda Verbeek, Rick Kaczowka, Patti Stevenson, Carnation Zhuwaki, Paul Grundy, Kent Stobart, Bev Wilson, Sunil Desai, Maria Spavor, Linda Churcher, Terence Chow, Kevin Hall, Nick Honcharik, Sara Israels, Shanna Chan, Byron Garnham, Michelle Staub, Geert 't Jong, Michael J Rieder, Becky Malkin, Carol Portwine, Amy Cranston, Gideon Koren, Shinya Ito, Paul Nathan, Mark Greenberg, Facundo Garcia Bournissen, Miho Inoue, Sachi Sakaguchi, Toshihiro Tanaka, Hisaki Fujii, Mina Ogawa, Ryoko Ingram, Taro Kamiya, Smita Karande, Sholeh Ghayoori, Mariana Silva, Stephanie Willing, Régis Vaillancourt, Donna Johnston, Herpreet Mankoo, Elaine Wong, Brenda Wilson, Lauren O'Connor, Caleb Hui, Cindy Yuen, Jean-Francois Bussières, Denis Lebel, Pierre Barret, Aurélie Clauson, Eve Courbon, Léna Cerruti, Nada Jabado, Anelise Espirito Santo, Martine Nagy, Margaret Murray, Darlene Boliver, Marilyn Tiller, Carol-anne Osborne, Lisa Goodyear, Lynette Bowes, Norma Kean & Jack Hand. (2015) A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nature Genetics 47:9, pages 1079-1084.
Crossref
Crossref
Elżbieta Sadurska. (2015) Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors. Pediatric Cardiology 36:6, pages 1112-1119.
Crossref
Crossref
Anita Ayer, Peter MacdonaldRoland Stocker. (2015)
CoQ
10
Function and Role in Heart Failure and Ischemic Heart Disease
. Annual Review of Nutrition 35:1, pages 175-213.
Crossref
Crossref
Susan Piper & Theresa McDonagh. (2015) Heart failure and chemotherapeutic agents. Future Cardiology 11:4, pages 453-470.
Crossref
Crossref
Christof Vulsteke, Alena M. Pfeil, Charlotte Maggen, Matthias Schwenkglenks, Ruth Pettengell, Thomas D. Szucs, Diether Lambrechts, Anne-Sophie Dieudonné, Sigrid Hatse, Patrick Neven, Robert Paridaens & Hans Wildiers. (2015) Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients. Breast Cancer Research and Treatment 152:1, pages 67-76.
Crossref
Crossref
Jan Hintzpeter, Jan Hornung, Bettina Ebert, Hans-Jörg Martin & Edmund Maser. (2015) Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase – Carbonyl reductase 1. Chemico-Biological Interactions 234, pages 162-168.
Crossref
Crossref
Angel Qin, Cheryl L. Thompson & Paula Silverman. (2014) Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin. Journal of Cancer Survivorship 9:2, pages 252-259.
Crossref
Crossref
Vivian Wu. (2014) Dexrazoxane. Journal of Pediatric Oncology Nursing 32:3, pages 178-184.
Crossref
Crossref
Constantinos M. Paleos, Zili Sideratou, Theodossis A. Theodossiou & Dimitris Tsiourvas. (2015) Carboxylated Hydroxyethyl Starch: A novel Polysaccharide for the Delivery of Doxorubicin. Chemical Biology & Drug Design 85:5, pages 653-658.
Crossref
Crossref
Sattar Ostadhadi, Mahdieh Rahmatollahi, Ahmad-Reza Dehpour & Reza Rahimian. (2015) Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review. Phytotherapy Research 29:3, pages 332-338.
Crossref
Crossref
Steven E. LipshultzVivian I. FrancoTracie L. MillerSteven D. ColanStephen E. Sallan. (2015) Cardiovascular Disease in Adult Survivors of Childhood Cancer. Annual Review of Medicine 66:1, pages 161-176.
Crossref
Crossref
Amal Zidan, Laila M. Sherief, Amera El-sheikh, Safaa H. Saleh, Doaa A. Shahbah, Naglaa M. Kamal, Hanan S. Sherbiny & Heba Ahmad. (2015) NT-proBNP as Early Marker of Subclinical Late Cardiotoxicity after Doxorubicin Therapy and Mediastinal Irradiation in Childhood Cancer Survivors. Disease Markers 2015, pages 1-10.
Crossref
Crossref
Wenping Zhang, Jin Sun, Wuhong Fang, Xiaoyu Ai, Cuifang Cai, Yilin Tang, Xiaonan Su, Zhi Feng, Yan Liu, Mengying Tao, Xiaodan Yan, Guoliang Chen & Zhonggui He. (2015) Nanomicelles based on X-shaped four-armed peglyated distearylglycerol as long circulating system for doxorubicin delivery. European Journal of Pharmaceutical Sciences 66, pages 96-106.
Crossref
Crossref
Michela Salvatici, Daniela Cardinale, Alessandro Colombo & Maria Teresa Sandri. 2015. Biomarkers in Cancer. Biomarkers in Cancer
73
105
.
David A. Briston, Thomas R. Cochran, Peter J. Sambatakos, Stefanie R. Brown & Steven E. Lipshultz. 2015. Survivors of Childhood and Adolescent Cancer. Survivors of Childhood and Adolescent Cancer
167
199
.
Berthe M. P. Aleman & David J. Cutter. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma
411
425
.
Nita Doshi, Vivian I. Franco, Anthony C. Chang & Steven E. Lipshultz. 2015. Handbook of Long Term Care of The Childhood Cancer Survivor. Handbook of Long Term Care of The Childhood Cancer Survivor
93
110
.
Merry L. LindseyRichard A. LangeHelen Parsons, Thomas Andrews & Gregory J. Aune. (2014) The tell-tale heart: molecular and cellular responses to childhood anthracycline exposure. American Journal of Physiology-Heart and Circulatory Physiology 307:10, pages H1379-H1389.
Crossref
Crossref
P.A. Janeesh & A. Abraham. (2014) Robinin modulates doxorubicin-induced cardiac apoptosis by TGF-β1 signaling pathway in Sprague Dawley rats. Biomedicine & Pharmacotherapy 68:8, pages 989-998.
Crossref
Crossref
Neha Bansal, Vivian I. Franco & Steven E. Lipshultz. (2014) Anthracycline cardiotoxicity in survivors of childhood cancer: Clinical course, protection, and treatment. Progress in Pediatric Cardiology 36:1-2, pages 11-18.
Crossref
Crossref
Michael S. Ewer, Steven M. Ewer & Thomas M. Suter. (2014) Cardiotoxicity in adults: An update. Progress in Pediatric Cardiology 36:1-2, pages 57-59.
Crossref
Crossref
Steven E. Lipshultz, Vivian I. Franco, Stephen E. Sallan, Peter C. Adamson, Rudolf K. Steiner, Sandra M. Swain, Joseph Gligorov & Giorgio Minotti. (2014) Dexrazoxane for reducing anthracycline-related cardiotoxicity in children with cancer: An update of the evidence. Progress in Pediatric Cardiology 36:1-2, pages 39-49.
Crossref
Crossref
Berthe M.P. Aleman, Elizabeth C. Moser, Janine Nuver, Thomas M. Suter, Maja V. Maraldo, Lena Specht, Conny Vrieling & Sarah C. Darby. (2014) Cardiovascular disease after cancer therapy. European Journal of Cancer Supplements 12:1, pages 18-28.
Crossref
Crossref
Shashi Raj, Vivian I. Franco & Steven E. Lipshultz. (2014) Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment. Current Treatment Options in Cardiovascular Medicine 16:6.
Crossref
Crossref
Alessandro Colombo, Maria T. Sandri, Michela Salvatici, Carlo M. Cipolla & Daniela Cardinale. (2014) Cardiac Complications of Chemotherapy: Role of Biomarkers. Current Treatment Options in Cardiovascular Medicine 16:6.
Crossref
Crossref
Andrew C. Dietz, Shanthi Sivanandam, Suma Konety, Christopher L. Kaufman, Ryan M. Gage, Aaron S. Kelly, Joseph P. Neglia & Daniel A. Mulrooney. (2013) Evaluation of traditional and novel measures of cardiac function to detect anthracycline-induced cardiotoxicity in survivors of childhood cancer. Journal of Cancer Survivorship 8:2, pages 183-189.
Crossref
Crossref
Jorge Eduardo Toblli, Carlos Rivas, Gabriel Cao, Jorge Fernando Giani, Felix Funk, Lee Mizzen & Fernando Pablo Dominici. (2014) Ferric Carboxymaltose-Mediated Attenuation of Doxorubicin-Induced Cardiotoxicity in an Iron Deficiency Rat Model. Chemotherapy Research and Practice 2014, pages 1-9.
Crossref
Crossref
Hui Zhang, Rongqin Zheng, Xiaoxian Qian, Chengxi Zhang, Baoshun Hao, Zeping Huang & Tao Wu. (2014) Use of Wave Intensity Analysis of Carotid Arteries in Identifying and Monitoring Left Ventricular Systolic Function Dynamics in Rabbits. Ultrasound in Medicine & Biology 40:3, pages 611-621.
Crossref
Crossref
Abdul Sattar Shaikh, Muhammad Matloob Alam, Shazia Samad Mohsin, Qalab Abbas, Zehra Fadoo & Mehnaz Atiq. (2014) Risk Factors Associated with Anthracycline Induced Cardiac Dysfunction in Pediatric Patients. World Journal of Cardiovascular Diseases 04:07, pages 377-383.
Crossref
Crossref
Steven E. Lipshultz, Peter Sambatakos, Michael Maguire, Ruchika Karnik, Samuel W. Ross, Vivian I. Franco & Tracie L. Miller. (2014) Cardiotoxicity and Cardioprotection in Childhood Cancer. Acta Haematologica 132:3-4, pages 391-399.
Crossref
Crossref
Steven E. Lipshultz, Ruchika Karnik, Peter Sambatakos, Vivian I. Franco, Samuel W. Ross & Tracie L. Miller. (2014) Anthracycline-related cardiotoxicity in childhood cancer survivors. Current Opinion in Cardiology 29:1, pages 103-112.
Crossref
Crossref
Francesco Corradi, Luca Paolini & Raffaele De Caterina. (2014) Ranolazine in the prevention of anthracycline cardiotoxicity. Pharmacological Research 79, pages 88-102.
Crossref
Crossref
Abdullah Kocabaş, Fırat Kardelen, Halil Ertuğ, Bilge Aldemir-Kocabaş, Özgür Tosun, Akif Yeşilipek, Volkan Hazar & Gayaz Akçurin. (2013) Assessment of Early-Onset Chronic Progressive Anthracycline Cardiotoxicity in Children: Different Response Patterns of Right and Left Ventricles. Pediatric Cardiology 35:1, pages 82-88.
Crossref
Crossref
Michela Salvatici, Daniela Cardinale, Alessandro Colombo & Maria Teresa Sandri. 2014. Biomarkers in Cancer. Biomarkers in Cancer
1
26
.
Berthe M. P. Aleman, Lena Specht & Ming Hui Chen. 2014. ALERT • Adverse Late Effects of Cancer Treatment. ALERT • Adverse Late Effects of Cancer Treatment
287
323
.
Steven E. Lipshultz, Thomas R. Cochran, Vivian I. Franco & Tracie L. Miller. (2013) Treatment-related cardiotoxicity in survivors of childhood cancer. Nature Reviews Clinical Oncology 10:12, pages 697-710.
Crossref
Crossref
Yinghuan Ma, Wanjun Kang, Yongxin Bao, Fubin Jiao & Yiran Ma. (2013) Clinical Significance of Ischemia-Modified Albumin in the Diagnosis of Doxorubicin-Induced Myocardial Injury in Breast Cancer Patients. PLoS ONE 8:11, pages e79426.
Crossref
Crossref
Onkar S. Bains, András Szeitz, Joanna M. Lubieniecka, Gina E. Cragg, Thomas A. Grigliatti, K. Wayne Riggs & Ronald E. Reid. (2013) A Correlation between Cytotoxicity and Reductase-Mediated Metabolism in Cell Lines Treated with Doxorubicin and Daunorubicin. Journal of Pharmacology and Experimental Therapeutics 347:2, pages 375-387.
Crossref
Crossref
Bandari Uma Mahesh, Shweta Shrivastava, Madhusudhana Kuncha, Bidya Dhar Sahu, Challa Veerabhadra Swamy, Rajeswara Rao Pragada, V.G.M. Naidu & Ramakrishna Sistla. (2013) Ethanolic extract of Boswellia ovalifoliolata bark and leaf attenuates doxorubicin-induced cardiotoxicity in mice. Environmental Toxicology and Pharmacology 36:3, pages 840-849.
Crossref
Crossref
Steven E. Lipshultz, M. Jacob Adams, Steven D. Colan, Louis S. Constine, Eugene H. Herman, Daphne T. Hsu, Melissa M. Hudson, Leontien C. Kremer, David C. Landy, Tracie L. Miller, Kevin C. Oeffinger, David N. Rosenthal, Craig A. Sable, Stephen E. Sallan, Gautam K. Singh, Julia Steinberger, Thomas R. Cochran & James D. Wilkinson. (2013) Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions. Circulation 128:17, pages 1927-1995.
Crossref
Crossref
Saro H. Armenian, Yan Ding, George Mills, Canlan Sun, Kalyanasundaram Venkataraman, Florence Lennie Wong, Susan L. Neuhausen, David Senitzer, Shirong Wang, Stephen J. Forman & Smita Bhatia. (2013) Genetic susceptibility to anthracycline‐related congestive heart failure in survivors of haematopoietic cell transplantation. British Journal of Haematology 163:2, pages 205-213.
Crossref
Crossref
Giorgio Minotti. (2013) Pharmacology at Work for Cardio-Oncology: Ranolazine to Treat Early Cardiotoxicity Induced by Antitumor Drugs. Journal of Pharmacology and Experimental Therapeutics 346:3, pages 343-349.
Crossref
Crossref
Alessandro Colombo, Carlo A. Meroni, Carlo M. Cipolla & Daniela Cardinale. (2013) Managing Cardiotoxicity of Chemotherapy. Current Treatment Options in Cardiovascular Medicine 15:4, pages 410-424.
Crossref
Crossref
Pei Jye Voon, Hui Ling Yap, Cho-Yee-Thu Ma, Fan Lu, Andrea L. A. Wong, Nur Sabrina Sapari, Richie Soong, Thomas I. P. Soh, Boon-Cher Goh, How-Sung Lee & Soo-Chin Lee. (2013) Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients. British Journal of Clinical Pharmacology 75:6, pages 1497-1505.
Crossref
Crossref
Qingbing Zeng, Hanbin Wen, Qing Wen, Xiaohui Chen, Yuegang Wang, Wanlin Xuan, Jiansheng Liang & Shanhe Wan. (2013) Cucumber mosaic virus as drug delivery vehicle for doxorubicin. Biomaterials 34:19, pages 4632-4642.
Crossref
Crossref
Alessandro Colombo, Carlo Cipolla, Marta Beggiato & Daniela Cardinale. (2013) Cardiac Toxicity of Anticancer Agents. Current Cardiology Reports 15:5.
Crossref
Crossref
Daniela Cardinale, Giulia Bacchiani, Marta Beggiato, Alessandro Colombo & Carlo M. Cipolla. (2013) Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients. Seminars in Oncology 40:2, pages 186-198.
Crossref
Crossref
Martin ŠtěrbaOlga PopelováAnna VávrováEduard JirkovskýPetra KovaříkováVladimír GeršlTomáš Šimůnek. (2013) Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection. Antioxidants & Redox Signaling 18:8, pages 899-929.
Crossref
Crossref
Emanuela Salvatorelli, Pierantonio Menna, Odalys Gonzalez Paz, Massimo Chello, Elvio Covino, Jack W. Singer & Giorgio Minotti. (2013) The Novel Anthracenedione, Pixantrone, Lacks Redox Activity and Inhibits Doxorubicinol Formation in Human Myocardium: Insight to Explain the Cardiac Safety of Pixantrone in Doxorubicin-Treated Patients. Journal of Pharmacology and Experimental Therapeutics 344:2, pages 467-478.
Crossref
Crossref
Marco Biondi, Daniela Guarnieri, Hui Yu, Valentina Belli & Paolo Antonio Netti. (2013)
Sub-100 nm biodegradable nanoparticles:
in vitro
release features and toxicity testing in 2D and 3D cell cultures
. Nanotechnology 24:4, pages 045101.
Crossref
Crossref
V.C. Fernandes, S.I.V. Pereira, J. Coppede, J.S. Martins, W.F. Rizo, R.O. Beleboni, M. Marins, P.S. Pereira, A.M.S. Pereira & A.L. Fachin. (2013) The epimer of kaurenoic acid from Croton antisyphiliticus is cytotoxic toward B-16 and HeLa tumor cells through apoptosis induction. Genetics and Molecular Research 12:2, pages 1005-1011.
Crossref
Crossref
Alessandro ColomboDaniela Cardinale. (2013) Using cardiac biomarkers and treating cardiotoxicity in cancer. Future Cardiology 9:1, pages 105-118.
Crossref
Crossref
G. Stephen Morris & Terry A. Wilson. (2013) Total Knee Arthroplasty in the Context of Cancer Survivorship. Topics in Geriatric Rehabilitation 29:1, pages 55-61.
Crossref
Crossref
Daria M. Adamczak. (2013) Kardionkologia – odpowiedź na wyzwania współczesnej terapii. Zeszyty Naukowe WCO, Letters in Oncology Science 10:1, pages 11-23.
Crossref
Crossref
James G. Gurney, Rohit P. Ojha, Kirsten K. Ness, Sujuan Huang, Shelly Sharma, Leslie L. Robison, Melissa M. Hudson & Sue C. Kaste. (2012) Abdominal aortic calcification in young adult survivors of childhood acute lymphoblastic leukemia: Results from the St. Jude Lifetime Cohort study. Pediatric Blood & Cancer 59:7, pages 1307-1309.
Crossref
Crossref
Priya Weerasinghe & L. Maximilian Buja. (2012) Oncosis: An important non-apoptotic mode of cell death. Experimental and Molecular Pathology 93:3, pages 302-308.
Crossref
Crossref
Menghao Cai, Xiangshan Zhou, Jian Lu, Weimin Fan, Jiushun Zhou, Chuanpeng Niu, Li Kang, Xueqian Sun & Yuanxing Zhang. (2012) An Integrated Control Strategy for the Fermentation of the Marine-Derived Fungus Aspergillus glaucus for the Production of Anti-cancer Polyketide. Marine Biotechnology 14:6, pages 665-671.
Crossref
Crossref
Christine Waibel Pachinger, Anne Rosselet, Stéphanie Berthouzoz, François Luthi & Nicolas Ketterer. (2012) Acute coronary syndrome upon receiving carmustine infusion before autologous stem‐cell transplantation. Hematological Oncology 30:4, pages 216-218.
Crossref
Crossref
Valentina K. Todorova, Marjorie L. Beggs, Robert R. Delongchamp, Ishwori Dhakal, Issam Makhoul, Jeanne Y. Wei & V. Suzanne Klimberg. (2012) Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model. PLoS ONE 7:11, pages e48398.
Crossref
Crossref
Annie CalvéWilliam NoilesIgal A. SebagLorraine E. Chalifour. (2012) The impact of doxorubicin and dexrazoxane injection of prepubertal female rats on pregnancy outcome and cardiac function postpartum. Canadian Journal of Physiology and Pharmacology 90:11, pages 1527-1534.
Crossref
Crossref
Steven E. LipshultzThomas R. CochranJames D. Wilkinson. (2012) Screening for Long-Term Cardiac Status During Cancer Treatment. Circulation: Cardiovascular Imaging 5:5, pages 555-558.
Crossref
Crossref
C. Elalouani, M.A. Benhmidoun, H. Rida, M. AitRaiss, N. Derhem, A. Elomrani, M. Khouchani, A. Tahri, A. Errehmouni, R. Faouzi, A. Elguenzri, M. Elhattaoui, I. Tazi & L. Mahmal. (2012) Cardiotoxicité à court et à moyen terme des anthracyclines : étude prospective. Annales de Cardiologie et d'Angéiologie 61:4, pages 257-266.
Crossref
Crossref
Danielle Harake, Vivian I Franco, Jacqueline M Henkel, Tracie L Miller & Steven E Lipshultz. (2012) Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiology 8:4, pages 647-670.
Crossref
Crossref
John M. Goldberg, Rebecca E. Scully, Stephen E. Sallan & Steven E. Lipshultz. (2012) Cardiac Failure 30 Years After Treatment Containing Anthracycline for Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 34:5, pages 395-397.
Crossref
Crossref
Mina Mhallem Gziri, Frédéric Amant, Frédéric Debiève, Kristel Van Calsteren, Luc De Catte & Luc Mertens. (2012) Effects of chemotherapy during pregnancy on the maternal and fetal heart. Prenatal Diagnosis 32:7, pages 614-619.
Crossref
Crossref
Annie Calvé, Rami Haddad, Sarah-Neiel Barama, Melissa Meilleur, Igal A. Sebag & Lorraine E. Chalifour. (2012) Cardiac response to doxorubicin and dexrazoxane in intact and ovariectomized young female rats at rest and after swim training. American Journal of Physiology-Heart and Circulatory Physiology 302:10, pages H2048-H2057.
Crossref
Crossref
O. El Mesbahi, F. Z. M’rabet, L. Ouaha, I. Lahlou, I. Najid & H. Akoudad. (2012) L’évaluation prospective de la fonction cardiaque chez les patientes traitées pour cancer du sein par anthtracyclines en adjuvant: résultats préliminairesProspective evaluation of cardiac function in breast cancer patients treated by anthracyclines in adjuvant sitting: first results. Journal Africain du Cancer / African Journal of Cancer 4:2, pages 95-100.
Crossref
Crossref
Steven E. LipshultzTracie L. MillerRebecca E. ScullyStuart R. LipsitzNader RifaiLewis B. SilvermanSteven D. ColanDonna S. NeubergSuzanne E. DahlbergJacqueline M. HenkelBarbara L. AsselinUma H. AthaleLuis A. ClavellCaroline LaverdièreBruno MichonMarshall A. SchorinStephen E. Sallan. (2012) Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes. Journal of Clinical Oncology 30:10, pages 1042-1049.
Crossref
Crossref
M. Hauser, R. Kandolf & J. Hess. (2011) Anthrazyklininduzierte Kardiomyopathie im KindesalterAnthracycline-induced cardiomyopathy in childhood. Monatsschrift Kinderheilkunde 160:2, pages 129-134.
Crossref
Crossref
Bonnie Ky. 2012. Echocardiography in Heart Failure. Echocardiography in Heart Failure
141
145
.
V. Ashutosh Rao, Jun Zhang, Sarah R. Klein, Parvaneh Espandiari, Alan Knapton, Jennifer S. Dickey, Eugene Herman & Emily B. Shacter. (2011) The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats. Cancer Chemotherapy and Pharmacology 68:5, pages 1125-1134.
Crossref
Crossref
Xavier Bosch, Jordi Esteve, Marta Sitges, Teresa M. de Caralt, Ariadna Domènech, José T. Ortiz, Mariano Monzó, Manuel Morales-Ruiz, Rosario J. Perea & Montserrat Rovira. (2011) Prevention of Chemotherapy-Induced Left Ventricular Dysfunction With Enalapril and Carvedilol: Rationale and Design of the OVERCOME Trial. Journal of Cardiac Failure 17:8, pages 643-648.
Crossref
Crossref
Wenping Zhang, Jin Sun, Zhi Feng, Xiaonan Su, Meng Zhu, Xiaofan Sui, Yan Liu, Mengying Tao, Yunqiang Sun, Guoliang Chen & Zhonggui He. (2011) Quantification of Doxorubicin in Pegylated Polymer Micelles in Rat Plasma by Methanol Precipitation–Ultrasonic Emulsion Breaking Method and UPLC–MS–MS. Chromatographia 74:3-4, pages 333-340.
Crossref
Crossref
Daniela Cardinale. (2011) Treatment and prevention of cardiotoxicity due to anticancer therapy. Journal of Cardiovascular Echography 21:2, pages 92-100.
Crossref
Crossref
Lynda M. Vrooman, Donna S. Neuberg, Kristen E. Stevenson, Barbara L. Asselin, Uma H. Athale, Luis Clavell, Peter D. Cole, Kara M. Kelly, Eric C. Larsen, Caroline Laverdière, Bruno Michon, Marshall Schorin, Cindy L. Schwartz, Harvey J. Cohen, Steven E. Lipshultz, Lewis B. Silverman & Stephen E. Sallan. (2011) The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium. European Journal of Cancer 47:9, pages 1373-1379.
Crossref
Crossref
Anna Vávrová, Olga Popelová, Martin Štěrba, Eduard Jirkovský, Pavlína Hašková, Helena Mertlíková-Kaiserová, Vladimír Geršl & Tomáš Šimůnek. (2010) In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity. Archives of Toxicology 85:5, pages 525-535.
Crossref
Crossref
Lidia Boccardi, Daniela Cardinale, Maurizio Civelli, Chiara Lestuzzi, Carlo Materazzo, Nicola Maurea, Ines Monte, Stefano Oliva, Patrizia Piotti, Giuseppina Quattrocchi, Elisabetta Rossi & Giuseppe Toglia. (2011) Approccio cardiologico al paziente sottoposto a trattamento antitumorale. Documento primo. Journal of Cardiovascular Echography 21:1, pages 32-41.
Crossref
Crossref
Barry H. Trachtenberg, David C. Landy, Vivian I. Franco, Jacqueline M. Henkel, Elliot J. Pearson, Tracie L. Miller & Steven E. Lipshultz. (2011) Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer. Pediatric Cardiology 32:3, pages 342-353.
Crossref
Crossref
Displaying 200 of 242 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list